Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 2Phase 3 1

Status

Terminated 2Completed 2Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 7Observational 6

Sponsor

Cancer Type

Breast 7

Conditions

Breast Neoplasms 7Prostatic Neoplasms 4Brain Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Sarcoma 2Multiple Myeloma 2Lung Neoplasms 2Glioma 2Glioblastoma 2Gastrointestinal Neoplasms 2Fatigue 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Weight Loss 1Uterine Cervical Neoplasms 1Thrombocytopenia 1Symptom Management 1Stomach Neoplasms 1Splenomegaly 1Sexual Dysfunction, Physiological 1Sex Cord-Gonadal Stromal Tumors 1Sarcoma, Synovial 1Rectal Neoplasms 1Peritoneal Neoplasms 1Pain 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroendocrine Tumors 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Quality of Life × Clear all
NCT06648278 2026-01-13

COUNTS2

University of California, San Francisco

Phase NA Recruiting
260 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases

NCT02900326 2025-12-19

MBSR

University Hospital, Strasbourg, France

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

NCT05932667 2023-12-21

DEMETER

Institut Curie

Phase 2 Terminated
1 enrolled
Breast

Breast Neoplasms

NCT04638712 2023-02-09

PROTECT-03

Institut de cancérologie Strasbourg Europe

Phase NA Completed
13 enrolled
Breast

Breast Neoplasms

NCT05670054 2023-01-04

Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients

Mansoura University

Phase 3 Unknown
116 enrolled
Breast

Breast Neoplasms

NCT03636776 2022-12-29

EPOCA

Institut Cancerologie de l'Ouest

Phase NA Terminated
60 enrolled
Breast

Breast Neoplasms

NCT00712621 2009-11-24

Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination

American Scitech International

Phase 2 Withdrawn
460 enrolled
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡